Ellen Johnson Sirleaf, former President of Liberia and Africa’s first elected woman president, on the impact of private sector investment, the urgency of action on climate change, and the resilience of developing countries.
CGD Policy Blogs
In 2016 on the CGD Podcast, we have discussed some of development's biggest questions: How do we pay for development? How do we measure the sustainable development goals (SDGs)? What should we do about refugees and migrants? And is there life yet in the notion of globalism? The links to all the full podcasts featured and the work they reference are below, but in this edition, we bring you highlights of some of those conversations.
Having tried and mostly failed to track what was going on with US Government performance and spending on Ebola, I welcome the GAO’s overview of obligations and disbursements by appropriation account and strategy pillar. Now the scope of this report appears to be narrow, so let’s hope there’s more to come. A performance audit should go beyond the money to look at what actually happened; what organizations, activities and products were funded; what were the results on the outcomes that matter—Ebola transmission, rapid control of Ebola outbreaks; whether second-order economic impacts were mitigated; and how outbreak preparedness has evolved over time.
This past weekend in Montreal, the Global Fund to Fight AIDS, TB and Malaria matched and exceeded its last three-year replenishment cycle with contributions of nearly $13 billion USD for its work, making the agency one of the world’s largest external funders for health in low-income countries.
The next US president will face ongoing and emerging global health crises. The next administration must work to transform the US approach to global health and global health security to protect the health of Americans here at home and ensure the long-term sustainability of US-supported health gains abroad. So, what changes should the next US president and administration implement? Here are our six concrete recommendations.
Health aid pays for life-saving medicines, products, and services in the poorest countries in the world. Funding for such uses needs to be smooth and uninterrupted. But when fraud is detected, funds are subject to sudden stops and starts—the result of a sequence of events set off by the scandal cycle in health aid. We examine this idea in a new CGD policy paper.
April 5 marked the official launch of our new book, Millions Saved: New Cases of Proven Success in Global Health. The new volume features case studies of 22 health programs from around the world and draws out what we can learn from each.
The International Decision Support Initiative Is Scaling Up—That Means Better Decisions and Better Health
The International Decision Support Initiative, initially launched as the result of a CGD working group, is scaling up, and that’s good news for people making life-and-death decisions in low- and middle-income countries. It means more data on what works and more guidance on how to get the most out of scarce resources for health.
My recent blog on cash transfers as a tool for HIV prevention among adolescent girls and young women left out results from a number of recent evaluations that illustrate the importance of program design and, in particular, targeting the transfers to the poorest households in getting results in wellbeing. Tia Palermo, a social policy specialist with the Transfer Project at UNICEF Office of Research-Innocenti and UNC-Chapel Hill, wrote with an update, which I’m pleased to share with her permission.